However, Jain et al. reported that RAF1 fusions in pediatric low-grade gliomas (PLGGs) may not respond to type I and II RAF inhibitors previously proven effective in tumors harboring BRAF fusions [148]. This evidence concerns the gene RAF1 and low grade glioma.